Results 201 to 210 of about 7,761,143 (347)

Impact of molecular diagnostics and targeted cancer therapy on patient outcomes (MODIFY): a retrospective study of the implementation of precision oncology

Molecular Oncology, EarlyView.
The authors conducted a retrospective study of 94 patients with advanced cancer who underwent next‐generation sequencing (NGS) gene panel analysis and received targeted treatments when applicable. Results further support evidence indicating that molecular profiling provides clinical benefit.
Michaël Dang, Anna Schritz, Nikolai Goncharenko, Guy Berchem   +3 more
wiley   +1 more source

Blockchain-Based Data Access Control and Key Agreement System in IoT Environment. [PDF]

Sensors (Basel), 2023
Lee J, Kim M, Park K, Noh S, Bisht A, Das AK, Park Y.   +6 more
europepmc   +1 more source

Cisapride to be taken off market, placed in controlled-access plan [PDF]

, 2000
John L. Miller
openalex   +1 more source

Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic DNA than in paired plasma cell‐free DNA samples as revealed by ddPCR

Molecular Oncology, EarlyView.
Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou, Aliki Ntzifa, Victoria Tserpeli, Ioanna Balgkouranidou, Alkistis Papatheodoridi, Evangelia Razis, Helena Linardou, Christos Papadimitriou, Amanda Psyrri, Flora Zagouri, Stylianos Kakolyris, Evi Lianidou   +11 more
wiley   +1 more source

Security verification framework for NDN access control. [PDF]

Sci Rep
Fei Y, Yin J, Yan L.
europepmc   +1 more source

A Scalable Cross-Chain Access Control and Identity Authentication Scheme. [PDF]

Sensors (Basel), 2023
Ding Y, Zhang Y, Qin B, Wang Q, Yang Z, Shi W.   +5 more
europepmc   +1 more source

Viewpoint: Technological access control interferes with noninfringing scholarship [PDF]

, 2000
Andrew W. Appel, Edward W. Felten
openalex   +1 more source

Robust acute myeloid leukemia engraftment in humanized scaffolds using injectable biomaterials and intravenous xenotransplantation

Molecular Oncology, EarlyView.
Patient‐derived xenografts (PDXs) can be improved by implantation of a humanized niche. We tested different biomaterials and approaches, and demonstrate that the combination of an injectable biomaterial for scaffold creation plus an intravenous route for acute myeloid leukemia (AML) xenotransplantation provide the most convenient and robust approach to
Daniel Busa, Zdenka Herudkova, Jan Hyl, Jakub Vlazny, Filip Sokol, Kvetoslava Matulova, Adam Folta, Jakub Hynst, Lucy Vojtova, Leos Kren, Martin Repko, Zdenek Racil, Jiri Mayer, Martin Culen   +13 more
wiley   +1 more source

MedAccessX: A Blockchain-Enabled Dynamic Access Control Framework for IoMT Networks. [PDF]

Sensors (Basel)
Shi G, Qi M, Zhong Q, Li N, Gao W, Zhang L, Gao L.   +6 more
europepmc   +1 more source

A technology transfer journey to a model-driven access control system. [PDF]

Int J Softw Tools Technol Transf, 2023
De Sanctis M, Di Salle A, Iovino L, Rossi MT.   +3 more
europepmc   +1 more source